Alzheimer's disease
Blood-based tests show potential for early Alzheimer’s detection
Blood-based tests show potential for early Alzheimer’s detection
More than 150 in vitro diagnostic tests are currently in development.
Neuroglee secures $10m funding to advance home-based Alzheimer's treatment
Openspace Ventures led the Series A round.
Join the community
Commentary
Strategic brand & design: A smart prescription to drive growth in healthcare